NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Meccellis Biotech

Meccellis Biotech

Private
La RochelleHealthcare & Life Scienceshttps://www.meccellis.com/

Last Round

Series B

Nov 14, 2022

Total Funding Raised

$8.53M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Meccellis Biotech is a medical device company that develops, manufactures, and markets biological implants based on acellular dermal matrices for dental, orthopedic, and visceral surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biological matrixacellular dermal matrixADMsurgical implantregenerative medicinesurgical meshbiomaterialtissue engineeringbiologic scaffoldhernia repairsoft tissue reinforcementreconstructive surgeryvisceral surgeryporcine dermismedical device manufacturer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Meccellis Biotech Comparables

Compare Meccellis Biotech with similar companies based on industry and business-model similarity.

Meccellis Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medtronic
80%
AbbVie
79%
MedSkin Solutions Dr. Suwelack
78%

Meccellis Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 14, 2022
Series ASep 1, 2018
SeedJul 6, 2015

Key People

Founding team and executive leadership

Anthony Pérès

CEO

Executive Team

Stéphane MILOT

Chief Financial Officer

Executive Team

Meccellis Biotech Investors

Notable investors and investment history

Meccellis Biotech investors
InvestorRounds
Banque PopulaireSeries B
BpifranceSeries B
Océan ParticipationsSeries A, Series B
European Regional Development FundSeries B
M CapitalSeries B
Région Nouvelle-AquitaineSeries B
European UnionSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2026

    Monthly visitors grew 40% MoM.

  • Apr 19, 2026

    Monthly visitors increased 162% MoM, reaching 1K.

Meccellis Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Meccellis Biotech Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersLa Rochelle
Employee Range10
Year Founded2011
Last FundingNov 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.